Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsIn honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.
GV101 receives FDA fast track designation for the treatment of Friedreich ataxia, with a phase 2 trial planned to begin enrollment in late 2026.
The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.
At a NeurologyLive Clinical Forum in Phoenix, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how a lack of adult neuro-oncology infrastructure is shaping how NF1-associated plexiform neurofibromas get recognized, referred, and treated.
Robert Bermel, MD, discusses advances in disease-modifying therapies, the challenges of monitoring MS progression, and emerging biomarkers and treatments that may address remaining unmet needs.
Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care
1.
Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
Two-part prodrug system activates immune attack only in tumor's unique environment
4.
Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts
5.
Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer?
1.
The Benefits and Side Effects of Vidaza Syndrome
2.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
3.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
4.
Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances
5.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Understanding Blood Clotting Disorders
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
5.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation